🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cliff Asness’s AVDL Holdings & Trades

First Buy
Q2 2025
Duration Held
3 Quarters
Largest Add
Q2 2025
+35,621 Shares
Current Position
19,963 Shares
$430,204 Value

Cliff Asness's AVDL Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 19,963 shares of Avadel Pharmaceuticals plc (AVDL) worth $430,204, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.

Based on 13F filings, Cliff Asness has maintained this position in AVDL for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 32,461 shares. Largest reduction occurred in Q4 2025, reducing 48,119 shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's Avadel Pharmaceuticals plc (AVDL) Holding Value Over Time

Track share changes against reported price movement

Quarterly Avadel Pharmaceuticals plc (AVDL) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 -48,119 Reduce 70.68% 19,963 $21.55
Q3 2025 +32,461 Add 91.13% 68,082 $15.27
Q2 2025 +35,621 New Buy 35,621 $8.85

Cliff Asness's Avadel Pharmaceuticals plc Investment FAQs

Cliff Asness first purchased Avadel Pharmaceuticals plc (AVDL) in Q2 2025, acquiring 35,621 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held Avadel Pharmaceuticals plc (AVDL) for 3 quarters since Q2 2025.

Cliff Asness's largest addition to Avadel Pharmaceuticals plc (AVDL) was in Q2 2025, adding 35,621 shares worth $315,247.

According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 19,963 shares of Avadel Pharmaceuticals plc (AVDL), valued at approximately $430,204.

As of the Q4 2025 filing, Avadel Pharmaceuticals plc (AVDL) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in Avadel Pharmaceuticals plc (AVDL) was 68,082 shares, as reported at the end of Q3 2025.